Protective effects of Thymus daenensis inhalation on ventilator-associated pneumonia

Ventilator-associated pneumonia (VAP) continues to pose a substantial challenge in intensive care units, contributing to increased morbidity, mortality, and healthcare costs. This review article explores the potential protective effects of Thymus daenensis inhalation in the treatment of VAP, with a focus on its key bioactive metabolites, thymol and carvacrol. These compounds exhibit broad-spectrum antimicrobial properties, making them promising candidates for managing not only VAP but also bacterial and fungal infections, asthma, and tuberculosis. Thymol and carvacrol have demonstrated efficacy in disrupting microbial cell membranes, modulating immune responses, and inhibiting biofilm formation, thereby reducing infection severity and promoting respiratory health. The article synthesizes findings from in vivo, in vitro, and clinical studies to provide a comprehensive overview of the mechanisms through which Thymus daenensis and its metabolites exert their protective effects. Additionally, the review highlights the potential therapeutic advantages of inhalation as a delivery method, ensuring targeted and efficient administration to the respiratory system. By integrating current knowledge on the antimicrobial and anti-inflammatory properties of thymol and carvacrol, This review highlights the potential of inhaled Thymus daenensis to complement the prevention and treatment of VAP and other respiratory issues. Further research is warranted to establish optimal dosing regimens, safety profiles, and clinical efficacy, paving the way for the development of novel therapeutic strategies in respiratory care.